Meeting
2022 ASCO Annual Meeting
Impact of molecular features on outcome in African American or Black women with type 1 endometrial cancer.
Authors
Roy Khalife
Protean BioDiagnostics, Orlando, FL
Roy Khalife , So Hyeon Park , Stephanie Erickson , Genevra Magliocco , Anthony Martin Magliocco
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5597)
DOI
10.1200/JCO.2022.40.16_suppl.5597
Abstract #
5597
Poster Bd #
473
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601).
First Author: Daniel D. Buchanan
Poster
2022 ASCO Annual Meeting
Racial differences in the mutational landscape of serous endometrial cancer.
First Author: Julian C. Schink
Poster
2021 ASCO Annual Meeting
Racial disparities in lung adenocarcinoma: The contribution of African ancestry.
First Author: Michelle Jeung-Eun Lee
Poster
2021 ASCO Annual Meeting
Racial differences in incidence, outcomes, and genomic alterations in small cell lung cancer.
First Author: Leyla Bayat